Skip to main content
. 2014 Apr 14;13:142. doi: 10.1186/1475-2875-13-142

Table 1.

In vitro activity of Aspidosperma olivaceum extracts and fractions against P. falciparum chloroquine-resistant blood parasites (W2 clone), cytotoxicity (MDL 50 ) to a human hepatoma cell line (HepG2), and selectivity index (SI), the ratio between the MDL 50 and IC 50

Compound* MDL 50 (μg/mL) IC 50 (μg/mL)**
SI***
[ 3 H]-hypoxanthine Anti-HRPII
Bark extract and fractions
 Crude bark extract
177 ± 4.0
10.6 ± 3.0
9.9 ± 4.5
17
 Acid fraction
330 ± 54.0
6.4 ± 2.3
5.5 ± 2.5
52
 Neutral fraction
20 ± 3.0
2.0 ± 0.2
2.1 ± 0.5
10
 Basic fraction
27 ± 0.0
4.3 ± 2.5
3.8 ± 0.4
<6
 Neutral precipitate (NP)
455 ± 100.0
6.7 ± 3.3
5.0 ± 2.5
68
Leaf extract and fractions
 
 
 
 
 Crude leaf extract
904 ± 135.4
7.2 ± 2.3
9.2 ± 5.4
126
 Basic residue
415 ± 98.8
4.5 ± 0.7
2.0 ± 1.5
92
 Acid fraction
441 ± 59.0
8.5 ± 3.5
5.3 ± 1.1
52
Pure substance from extracts*
 
 
 
 
 (1) Aspidoscarpine #
301 ± 24.0
5.4 ± 2.5
4.4 ± 0.8
56
 (2) Uleine
52 ± 10.0
7.0 ± 0.0
3.2 ± 1.8
18
 (3) Apparacine
41 ± 2.8
3.0 ± 1.4
3.2 ± 2.7
14
 (5 N-methyl-tetrahydrolivacine 126 ± 6.0 5.7 ± 3.3 4.0 ± 2.8 22

*The steps for the bio-fractionation of the extracts are summarized in Figure 1.

**IC50 = dose inhibiting 50% of parasite growth, evaluated in three or four different experiments for each test.

***SI = values obtained using the [3H]-hypoxanthine test; toxicity considered present at an SI <10.

#Compound (1) was isolated from the leaves and bark. The compounds are numbered 1, 2, 3, and 5 as in Figure 2; their complete names and structures are listed in Figure 1.